PAVmed Partners with OSUCCC to Revolutionize Cancer Care with Veris Cancer Care Platform

PAVmed Partners with OSUCCC to Enhance Cancer Care through Technology

PAVmed Inc. is making significant strides in cancer treatment technology with the commercial launch of its Veris Cancer Care Platform, developed in collaboration with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). This partnership marks a key advancement in personalized cancer care for patients undergoing systemic therapy. The Veris Cancer Care Platform is designed to improve patient outcomes by integrating remote physiological data collection, symptom reporting, telehealth capabilities, and electronic health record integration. This comprehensive approach aims to detect complications early and minimize unplanned hospitalizations, ultimately enhancing the quality of care patients receive.

The platform's functionality is centered around the VerisBox™, a collection of connected health devices that allow continuous data transmission to a secure cloud-based clinician portal. This innovation not only facilitates real-time monitoring by healthcare providers but also empowers patients through a smartphone app that enables them to report symptoms and share health parameters. Family members and caregivers can also engage in the care process, staying informed and involved as patients navigate their treatment journey. This focus on connectivity and communication represents a transformative step in the management of cancer care, aligning with the growing trend of patient-centered healthcare solutions.

Additionally, the collaboration includes the establishment of a clinical registry for patients enrolled in the Veris Cancer Care Platform. This registry will enable OSUCCC – James to enhance their engagement with patients beyond traditional clinical settings, allowing for a more comprehensive understanding of patient experiences and outcomes. Dr. David Cohn, COO and CMO at The James Cancer Hospital, emphasizes that this partnership is pivotal in their mission to deliver innovative and personalized cancer care. By leveraging technology and data, PAVmed and OSUCCC aim to set a new standard in cancer treatment, ensuring that every patient receives tailored care that meets their unique needs.

In summary, PAVmed's partnership with OSUCCC – James represents a crucial development in medical technology, focusing on improving cancer care through innovative digital solutions. The Veris Cancer Care Platform not only facilitates better patient monitoring and engagement but also seeks to reduce hospitalizations and enhance overall treatment experiences. As the landscape of cancer care evolves, this collaboration is positioned to lead the way in personalized treatment approaches.